Pablo Guasp

PhD. Postdoc at @TheVinodLab. Cancer Immunology @MSKCancerCenter

[Pablo Guasp @PabloGuasp]

I am excited to share our new work on personalized mRNA vaccines in pancreatic cancer in @Nature: https://t.co/yNKV0637XK
Great thread below by @TheVinodLab explaining the findings. As always, it is a pleasure to be part of this team with such great colleagues and friends.

[Vinod BalachandranMD @TheVinodLab]

#mRNAvaccines for #PancreaticCancer (PDAC) PART4

1. Out today in @Nature https://t.co/NhpkJeaQYb

🧵👇🏽

[1/23]

[Pablo Guasp @PabloGuasp]

Congrats @m_amisaki and @A_Zebboudj for this amazing work

[Vinod BalachandranMD @TheVinodLab]

1. Tertiary Lymphoid Structures (TLSs) – on demand lymphoid aggregates that assemble in inflamed tissues/cancer to regulate immunity

But how? What molecule triggers? What cells induce?

TODAY in @Nature https://t.co/vTh33onmjh

Long-term #PDAC survivor PART4 – TLSs

🧵1/25

[AACR @AACR]

Cancer Vaccines:
Catherine J. Wu, Vinod P. Balachandran, Lorenzo De Marco, Pablo Guasp, and Marie-Pierre Hardy discussed this topic in a plenary session at the AACR Special Conference on Tumor Immunology and Immunotherapy. #AACRtii24 @TheVinodLab @PabloGuasp

[Pablo Guasp @PabloGuasp]

Proud doesn't start beggining to describe how I feel. I am lucky to have witnessed how this idea grew trough hard work and resilience to become such an incredible and rigorous work. Can't wait to see what you come up with next @melodyDiBona

[MSK Library @MSKLibrary]

Featured today by @MSKLibrary: RNA vaccines for cancer: Principles to practice https://t.co/lgTVMwDxUO
#RNA #Vaccine #Neoantigen #Cancer
@PabloGuasp @CharReiche @TheVinodLab

[Pablo Guasp @PabloGuasp]

Exciting times for cancer vaccines as mRNA leads the charge! Insights from vaccines against pathogens pave the way for personalized cancer vaccination. @CharReiche, Zachary Sethna, @TheVinodLab, and myself discuss this and much more in our newly published review in @Cancer_Cell

[Vinod BalachandranMD @TheVinodLab]

Interested to learn about #RNAVaccines for #cancer?

Our thoughts now in @Cancer_Cell

RNA Vaccines for cancer: Principles to Practice
https://t.co/FxMJViXTFK

Free pdf is here 👇🏽

https://t.co/5c8EIbphox

[Pablo Guasp @PabloGuasp]

I am excited to present the latest work we are doing in @TheVinodLab next week at #ASGCT2024. Come by Ballroom 2 at 1.30pm on May 8th to hear about Personalized #CancerVaccines in Pancreatic Cancer.

[Memorial Sloan Kettering Cancer Center @MSKCancerCenter]

Research presented by @TheVinodLab at #AACR24 shows that an investigational approach to treating #pancreaticcancer w/an #mRNA-based vaccine activates immune cells that can persist in the body for up to three years after treatment in certain patients. https://t.co/Ju5ftYSYa1

[Pablo Guasp @PabloGuasp]

Everything is ready to start this #SU2CScienceSummit Can't wait to see all the amazing science that will be shared here. With @SU2CScience @CharReiche @Martina_Milig

[Pablo Guasp @PabloGuasp]

Very interesting review by the talented @melodyDiBona about micronuclei in chromosomally unstable cancers

[Cristina Muñoz Pinedo @crismunozp]

Consejos para quien quiera empezar como IP en España.
Advice for those aiming to start a group as PI in Spain
---------------------------------------------
Muchos me piden consejo, que yo no pedí adecuadamente. Aquí van mis reflexiones después de 17 años de IP en Biomedicina 👇

[Pablo Guasp @PabloGuasp]

@MSKPDA people have spoken, for the next 4 years "Nightmare before Christmas" will be considered a Halloween movie 🎃👻🍬

[BioNTech SE @BioNTech_Group]

We announced today that the first patient has been treated in a #PDAC Ph2 clinical trial with our individualized #mRNA cancer immunotherapy candidate autogene cevumeran. https://t.co/HjPkhD4La1

[Pablo Guasp @PabloGuasp]

Proud and happy to be featured as a #MSKPostdoc. Working in an institution such as @MSKCancerCenter is amazing. A special thanks to @melodyDiBona for the continuous and unconditional support

[Pablo Guasp @PabloGuasp]

@sonrie369 Almas gemelas
https://t.co/zm8uMT1Yp5

[Memorial Sloan Kettering Cancer Center @MSKCancerCenter]

Vaccines and cancer are in the news. On the latest episode of the Cancer Straight Talk Podcast from MSK, Drs. Vinod Balachandran (@thevinodlab) and @DmitriyZamarin speak with Dr. @DianeReidyLagun about their research into cancer vaccines. Listen here: https://t.co/5st0cQFIsH

[Pablo Guasp @PabloGuasp]

Amazing work published in @Nature by my colleagues Luis Rojas and Zachary Sethna at @TheVinodLab. It is an honor to be part of this team working on #mRNAvaccines in #cancer

[Vinod BalachandranMD @TheVinodLab]

1. ENTER #mRNAvaccines for #pancreaticcancer! Long-term #PDAC survivor story PART3.

"Do #PDACs REALLY have vaccine neoantigens (NAs)"? (aren’t they lowly mutated?)

If each patient = own NAs, how do you vaccinate?

Maybe mRNA? But how?

@Nature https://t.co/d1SgGgdVHq

👇🏽 [1/32]

[Pablo Guasp @PabloGuasp]

Happy to see our work is out! Here we studied the presence of subpeptidomes in different HLA molecules of the B7 supertype. It was a pleasure working with Iñaki Alvarez and Adrián Tirado from @UABBarcelona
https://t.co/USp7MdtYPt

[Sanjee Baksh @S__Baksh]

T-cells on their way to a tumor vs when they’re in a tumor

[nature @Nature]

‘Ignored and not appreciated’: Women’s research contributions often go unrecognized https://t.co/XYBHnVh1GY